(NYSE: TRLV) Trulieve Cannabis's forecast annual revenue growth rate of -9.89% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.56%.
Trulieve Cannabis's revenue in 2026 is $1,081,068,000.On average, 9 Wall Street analysts forecast TRLV's revenue for 2026 to be $177,968,778,617, with the lowest TRLV revenue forecast at $170,612,849,522, and the highest TRLV revenue forecast at $183,428,990,425. On average, 9 Wall Street analysts forecast TRLV's revenue for 2027 to be $166,587,649,630, with the lowest TRLV revenue forecast at $156,721,729,419, and the highest TRLV revenue forecast at $179,163,199,950.
In 2028, TRLV is forecast to generate $94,262,025,284 in revenue, with the lowest revenue forecast at $20,300,043,712 and the highest revenue forecast at $172,337,935,190.